Deucravacitinib
Deucravacitinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Deucravacitinib is under investigation in clinical trial NCT04772079 (A Study to Evaluate the Drug Levels, Efficacy and Safety of BMS-986165 in Adolescent Participants With Moderate to Severe Plaque Psoriasis).
| Trade Name | Deucravacitinib |
| Generic | Deucravacitinib |
| Deucravacitinib Other Names | Deucravacitinib |
| Type | |
| Formula | C20H22N8O3 |
| Weight | Average: 425.467 Monoisotopic: 425.200316838 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Deucravacitinib
